Online Courses for Other HCP's

A complete listing of currently available online programs is provided below. To access course materials and claim credit you must be registered and logged-in. Courses of interest must be selected and added to your FCMCME.org user account. Once selected course material links will be provided from within your individual User Record section of this website.

Sort by: Title | Newest
* Thyroid Update Part 1: Thyroid hormone replacement with thyroxine is no longer indicated for SCH based on new guidelines.
Presented by: Neal Rouzier, MD
Effective Date: June 12, 2019
Expiration Date: June 12, 2021
Credits: 1
Format:
Fee: $15.00

New guidelines recommend not treating subclinical hypothyroidism, particularly if the TSH is <20.  Recent studies demonstrate that patients do not improve symptomatically and that treatment can be harmful.  During the webinar, I will review the British Medical Journal and explain their recommendations and how they came to their conclusions. In part 2 next month, I will review the studies that prove thyroid hormone does improve symptoms when prescribed correctly and how it can treat "Estrogen Dominance" in both men and women.

Outcome Objectives:

  1. Review a recent meta-analysis of 21 studies demonstrating that thyroxine does not improve symptoms or quality of life in patients with SCH.
  2. Recognize that there is no clear evidence that symptoms are related to serum TSH levels.
  3. Critique the reasons as to why experts make a strong recommendation against the use of thyroid hormones, even in symptomatic patients with significant elevation of TSH.
  4. Discuss their logic in recommendations against thyroid hormone use due to the "potential harm, lack of benefit, being burdensome of some patients because of long-term daily medication requirements, the cost of follow up visits and testing, all of which stress the patient without any benefits."
  5. Evaluate an opinion by an esteemed psychiatrist that hypothyroid patients, or patients with hypothyroid symptoms, should not be evaluated or treated by endocrinologists. 

To fully participate in this activity you must be registered and logged in to the website.

Selection Required to View & Claim Credit

Case Studies In Heart Failure
Presented by: Nicholas D. Wyatt, PharmD | Peter J. Kudenchuk, MD
Effective Date: February 01, 2017
Expiration Date: March 01, 2020
Credits: 2.5
Format: Webinar
Fee: $60.00
16747

Heart failure impacts the lives of thousands upon thousands of patients as well as their family members every year. The disease cost the healthcare system billions of dollars every year and is expected to continue to rise.

This course will give the participant the resources and tools necessary to become a heart failure expert. Our discussion will start with the epidemiology of heart failure. Then we will transition into discussing the stages of heart failure, specifically focusing on the four stages of heart failure and the evidence treatments of these four stages. Thanking you for joining me on your journey to becoming a heart failure expert. Let' get started.

Outcome Objectives
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Describe the clinical epidemiology of heart failure and its impact on health care delivery and costs.
  2. List the modifiable risk factors of heart failure
  3. Identify the non-modifiable risk factors of heart failure
  4. Describe the population attribution risk of heart failure for modifiable and non-modifiable risk factors
  5. Define the four stages of the ACC/AHA heart failure staging model.
  6. Describe the four classification stages of the NYHA heart failure staging model.
  7. Describe the neurohormonal response in patients with and without heart failure.
  8. Identify key compensatory neurohormones in heart failure patients.
  9. Describe the renin-angiotension system response in patients with heart failure.
  10. List the compensatory responses that maintain circulation as a result of decreased cardiac output.
  11. Name two biomarkers used in the diagnosis and assessment heart failure.
  12. Discuss the four components of examining the heart failure patient.

To participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit

Chronic Fatigue Syndrome and Hypothyroidism Are Linked To Low T3 Syndrome
Presented by: Neal Rouzier, MD
Effective Date: July 11, 2018
Expiration Date: July 11, 2020
Credits: 1.0
Format: Webinar
Fee: $30.00
17563

Dr. Rouzier, will be reviewing Chronic Fatigue Syndrome and how the signs and symptoms are similar, to hypothyroidism. How many times these conditions are misdiagnosed and how to interpret your patient's medical condition to improve clinical outcomes.

Outcome Objectives:
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Review the work-up and diagnosis of Chronic Fatigue Syndrome.
  2. Recognize the many inflamed hormonal pathways in CFS.
  3. Discuss the pathophysiology involved in the development of CFS.
  4. Review thyroid lab tests as they pertain to CFS.
  5. Identify why it is called the hypometabolic syndrome.
  6. Review the studies that support normalizing TSH levels does NOT result in clinical euthyroidism.

To fully participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit

Clinical Diagnosis and Treatment for Complex Female HRT Patients
Presented by: Ilona Bleaman, PA-C, MHPE
Effective Date: April 11, 2018
Expiration Date: April 11, 2020
Credits: 1.0
Format: Webinar
Fee: $15.00
17634

Women in their thirties well into their fifties commonly present to the office complaining of fatigue, weight gain, insomnia, irritability, acne, hair loss and decreased libido. Whether the patient is complaining of one or all of the above it is apparent that her quality of life is being affected. Many of these symptoms are frequently related to an imbalance or declining of their hormones.

Upon closer examination and analysis of patients’ prior lab work compared with current blood results it became apparent that often times only symptoms are being treated and not the underlying cause. For example, a 38 year old female with acne is commonly prescribed spironolactone yet the underlying origin or disease process, Polycystic Ovary Syndrome, is not identified or addressed. Additionally, perimenopausal women are often misdiagnosed and then prescribed inappropriate hormone regimens that result in an increase or new symptoms.

The intention of this webinar is to highlight and review a variety of cases with atypical patient presentations focusing on perimenopause and Polycystic Ovary Syndrome. The webinar identifies patients’ chief complaints and discusses their lab results. With this information an appropriate treatment plan is then developed. Practical clinical pearls are identified throughout the presentation.

To fully participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit

Endobronchial Ultrasonography: A Practical Approach
Presented by: Gustavo Cumbo Nacheli, MD FCCP DAABIP | John Egan III, MD FCCP DAABIP
Effective Date: February 01, 2019
Expiration Date: January 31, 2021
Credits: 1.0
Format: Webinar
Fee: $15.00
17772

Society for Advanced Bronchoscopy (SAB) Archived Presentation January 2019

Often times first step on workup for intrathoracic abnormalities involve transthoracic sample acquisition. Understanding correct EBUS application and patient section are key to perform the correct procedure and expedites proper treatment.

At the conclusion of the webinar, the learner should have gained an enhanced understanding of intrathoracic lymph node anatomy, sampling techniques, and clinical usefulness of various endobronchial ultrasound guided diagnostic approaches; thereby improving patient outcomes.

Following the presentation questions from the audience were addressed in a moderated Q&A session.

Selection Required to View & Claim Credit

Nitric Oxide Therapeutic Intervention: Bridging the Gap Between Microvascular Dysfunction and Cognitive Impairment
Presented by: Nathan S. Bryan, Ph.D
Effective Date: September 01, 2019
Expiration Date: August 31, 2021
Credits: 1.0
Format: Webinar
Fee: $30.00
17998

In this presentation, Nathan S. Bryan will provide an overview of the atmospheric and human nitrogen cycles and nitric oxide production pathways in humans. He will review evidence based nitric oxide research specific to vascular function and structure. In addition to nitric oxide production, he will review the importance of nitrate and how much is recommended daily for health benefits. Dr. Bryan will also discuss nitric oxide therapeutic interventional outcome data and how to control and regulate nitric oxide production

Outcome Objectives
Upon completion of this CME activity the healthcare provider will be able to:

  1. Recognize nitric oxide production pathways in humans.
  2. Demonstrate evidence on how NO affects vascular structure and function.
  3. Communicate evidence based nutritional strategies to restore and replete NO production in humans to restore vascular structure and function.

Selection Required to View & Claim Credit

Opioid Addiction: Challenging Cases in Diagnosis, Treatment, and Prevention
Presented by: Christine Mintz, MD
Effective Date: June 19, 2018
Expiration Date: June 19, 2020
Credits: 1.0
Format: Webinar
Fee: $15.00
17297

It is estimated that each day more than 1000 people are treated in emergency departments for not using prescription opioids as prescribed. Combine this with illicit drug use and the cost of treatment and productivity losses related to addiction and we have a current epidemic costing Americans over 500 billion dollars and rising.

This interactive course will give the participant the resources and tools necessary to identify, educate and treat opioid tolerant and opioid addicted patients in primary care. We will cover the pathophysiology of opioids and their receptors, then we will transition to discussing tolerance vs. withdrawal and addiction. We will also review overdose antagonist medications, medication assisted treatments as well as briefly discuss new treatments and research on the horizon.

Outcome Objectives:
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Describe the pathophysiology of opioid receptors in the dopamine reward pathway and how different opioids and opioid antagonists interact and bind to these receptors.
  2. Describe the common clinical features of chronic opioid abuse and suspected opioid withdrawal including appropriate diagnostic work-up.
  3. Discuss the current best practice treatment options for suspected opioid overdose including routes of administration and formulations as well as medication assisted treatment options.
  4. Identify new or emerging areas of research and treatment options for opioid dependence including pharmacologic and psychosocial strategies.

To fully participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit

Reversal of Cognitive Decline: The Science, The Tools, and The Transformation
Presented by: Kenneth S. Sharlin, M.D., M.P.H., IFMCP
Effective Date: August 01, 2019
Expiration Date: August 01, 2021
Credits: 1.0
Format: Webinar
Fee: $20.00
17912

This presentation will address the burden of Alzheimer’s disease in the United States and the role of amyloid beta in the progression of this disease. You will be given the tools to help prevent Alzheimer’s disease through lifestyle medicine and modification.

Outcome Objectives
Upon completion of this CME activity the healthcare provider will be able to:

  1. Outline the burden of Alzheimer’s disease in the United States.
  2. Describe the role that the lipid-binding protein APoE4 plays in modifying the risk of Alzheimer’s disease.
  3. List at least two normal roles for amyloid beta in the brain.
  4. Describe the solutions lifestyle medicine provides to address the burden of Alzheimer’s disease.

Selection Required to View & Claim Credit